Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?
Barter
Philip J
PJ
Rye
Kerry-Anne
KA
D002316:Cardiotonic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002995:Clofibric Acid / Q000494:pharmacology* / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control; D015248:Gemfibrozil / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects; D008055:Lipids / Q000097:blood
D002316:Cardiotonic Agents; D008055:Lipids; D002995:Clofibric Acid; D015248:Gemfibrozil